Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-28 Benaim Ely Chief Medical Officer Exercise or conversion +2,375 4,750
2019-02-28 Benaim Ely Chief Medical Officer Exercise or conversion · Restricted Stock Units −2,375 4,750
2019-01-25 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2018-03-07 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2018-02-28 Benaim Ely Chief Medical Officer Exercise or conversion +2,375 2,375
2018-02-28 Benaim Ely Chief Medical Officer Exercise or conversion · Restricted Stock Units +2,375 7,125
2018-01-26 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +45,443 45,443
2017-01-20 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +450,000 450,000
2017-01-20 Benaim Ely Chief Medical Officer Grant or award · Restricted Stock Units +95,000 95,000
2016-01-28 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +98,734 98,734
2016-01-28 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +500,000 500,000
2015-02-02 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +1,200,000 1,200,000

Page 1 of 1 · 12 trades